ArticleOncoimmunology2021

Cancer cells under immune attack acquire CD47-mediated adaptive immune resistance independent of the myeloid CD47-SIRPα axis.

Mark A J M Hendriks et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.